HIGHLIGHTS
- who: Shuai Liu and Dan Zhao from the Jawaharlal Institute of Postgraduate (JIPMER), India North-West University, South Africa have published the research: Mental distress, quality of life and physical symptoms in Chinese women with ovarian cancer receiving olaparib treatment during the COVID-19 pandemic, in the Journal: (JOURNAL)
- what: The authors attempted to evaluate the experience and explore the potential risk factors of mental distress and reduced QoL among OC patients who were receiving oral olaparib treatment during the COVID19 pandemic.
SUMMARY
Accordingly, in this study, the authors attempted to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.